Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Macrolid, Theophylline, Inhaler Corticosteroids
- Registration Number
- NCT01010178
- Lead Sponsor
- Baqiyatallah Medical Sciences University
- Brief Summary
Critical combination of various approved drugs in management for patients suffering with COPD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- current or past smoker COPD
Exclusion Criteria
- history of significant occupational or other environmental exposures or a connective tissue disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Macrolid, Theophylline, Corticosteroids Macrolid, Theophylline, Inhaler Corticosteroids Approved drug in this setting
- Primary Outcome Measures
Name Time Method 15% increasing in forced expiratory volume in 1 second 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Mollasadra St,
🇮🇷Tehran, Iran, Islamic Republic of